| In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector E Zinn, S Pacouret, V Khaychuk, HT Turunen, LS Carvalho, ... Cell reports 12 (6), 1056-1068, 2015 | 341 | 2015 |
| Adeno-associated virus: fit to serve E Zinn, LH Vandenberghe Current opinion in virology 8, 90-97, 2014 | 137 | 2014 |
| GPR108 is a highly conserved AAV entry factor AM Dudek, N Zabaleta, E Zinn, S Pillay, J Zengel, C Porter, ... Molecular Therapy 28 (2), 367-381, 2020 | 96 | 2020 |
| An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates N Zabaleta, W Dai, U Bhatt, C Hérate, P Maisonnasse, JA Chichester, ... Cell host & microbe 29 (9), 1437-1453. e8, 2021 | 56 | 2021 |
| Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In Vivo LS Carvalho, R Xiao, SJ Wassmer, A Langsdorf, E Zinn, S Pacouret, ... Human Gene Therapy 29 (7), 771-784, 2018 | 56 | 2018 |
| Methods of predicting ancestral virus sequences and uses thereof LH Vandenberghe, E Zinn US Patent 9,695,220, 2017 | 44 | 2017 |
| Methods of predicting ancestral virus sequences and uses thereof LH Vandenberghe, E Zinn US Patent 9,719,070, 2017 | 35 | 2017 |
| Cross-packaging and capsid mosaic formation in multiplexed AAV libraries PF Schmit, S Pacouret, E Zinn, E Telford, F Nicolaou, F Broucque, ... Molecular Therapy-Methods & Clinical Development 17, 107-121, 2020 | 31 | 2020 |
| Methods of predicting ancestral virus sequences and uses thereof LH Vandenberghe, E Zinn US Patent 10,119,125, 2018 | 23 | 2018 |
| High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography M Florea, F Nicolaou, S Pacouret, EM Zinn, J Sanmiguel, ... Molecular Therapy Methods & Clinical Development 28, 146-159, 2023 | 20 | 2023 |
| Gene therapy: paving new roads in the treatment of hemophilia GG Yamaguti-Hayakawa, MC Ozelo Seminars in thrombosis and hemostasis 45 (07), 743-750, 2019 | 20 | 2019 |
| Ancestral library identifies conserved reprogrammable liver motif on AAV capsid E Zinn, C Unzu, PF Schmit, HT Turunen, N Zabaleta, J Sanmiguel, ... Cell Reports Medicine 3 (11), 2022 | 12 | 2022 |
| Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mouse and non-human primates N Zabaleta, W Dai, U Bhatt, JA Chichester, J Sanmiguel, R Estelien, ... bioRxiv, 2021.01. 05.422952, 2021 | 12 | 2021 |
| In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector. Cell Rep 12: 1056–1068 E Zinn, S Pacouret, V Khaychuk, HT Turunen, LS Carvalho, ... | 12 | 2015 |
| Ancestral virus sequences and uses thereof LH Vandenberghe, E Zinn US Patent 10,738,087, 2020 | 9 | 2020 |
| Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1F CW Peters, KS Hanlon, MV Ivanchenko, E Zinn, EF Linarte, Y Li, JM Levy, ... Molecular Therapy 31 (8), 2439-2453, 2023 | 8 | 2023 |
| Methods of predicting ancestral virus sequences and uses thereof LH Vandenberghe, E Zinn US Patent 10,526,584, 2020 | 8 | 2020 |
| In Silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector. Cell Rep. 2015; 12 (6): 1056–68 E Zinn, S Pacouret, V Khaychuk, HT Turunen, LS Carvalho, ... | 4 | |
| Methods of predicting ancestral virus sequences and uses thereof LH Vandenberghe, E Zinn US Patent 11,104,885, 2021 | 3 | 2021 |
| Multiplexed Neutralizing Antibody Assay Identifies Potential Epitopes on the AAV Capsid P Schmit, E Zinn, A Fieldsend, L Vandenberghe MOLECULAR THERAPY 28 (4), 520-520, 2020 | 2 | 2020 |
Luk H. Vandenberghe, Ph.D.Grousbeck Family Chair in Gene Therapy, Associate Professor of Ophthalmology, Harvard UniversityVerified email at meei.harvard.edu
